The Drugs Controller General of India (DCGI) is creating a plan for a new e-governance system that will allow companies in the country running clinical trials a way to apply online for all approval processes. According to the Business Standard, this allows both the ministry and those who have conducting research to have an online portal where they can access the latest information and data coming out of their trials. It is also a way to maintain and track data throughout the approval process. The effort is in support of creating more transparency and accountability for all drug approval processes taking place in the country.
This September at Partnerships in Clinical Trials Asia, Sumant Tiwari, Deputy Director, Drugs, Food & Drug Administration (FDA), will be joining us to discuss the extent that India has improved its approval timelines in global clinical trials. For more information on Tiwari's session and the rest of the program, download the agenda. If you'd like to join him this September 16-18 in Shanghai, as a reader of this blog, when you register to join us and mention code XP1975BLOG, you can save 15% off the standard rate!
What effects do you think these new transparency efforts will have on the clinical trials industry in India?
The Partnerships in Clinical Trials Blog focuses on optimization intelligence, regulatory trends and globalization strategies for both sponsors and CROs. It is supported by a number of industry events.
Would you like to guest blog on our site? Or send us feedback? Send an email to email@example.com.